Dusseldorf - Delayed Quote EUR
BioNTech SE (22UA.DU)
92.65
+1.70
+(1.87%)
At close: May 2 at 7:31:33 PM GMT+2
Key Executives
Key Executives Information Not Available
BioNTech SE
Profile Information Not Available
Description
Description Information Not Available
Corporate Governance
BioNTech SE’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
May 5, 2025 at 12:30 PM UTC
BioNTech SE Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
HTD.SG Corcept Therapeutics Inc
64.08
+1.65%
0OT.DU Ocular Therapeutix Inc
7.67
+4.78%
328.SG MeiraGTx Holdings PLC
6.45
+4.03%
VX1.DU Vertex Pharmaceuticals Inc
440.35
-0.94%
VX1.MU Vertex Pharmaceuticals Inc
439.25
-0.82%
BT3.BE Lineage Cell Therapeutics Inc
0.4320
+7.46%
HTD.MU Corcept Therapeutics Inc
63.62
0.00%
VX1.HA Vertex Pharmaceuticals Inc
439.60
-0.92%
1T3.BE Syndax Pharmaceuticals Inc
12.00
-4.00%
25I.SG ImmuPharma PLC
0.0325
-1.52%